• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.14% Nasdaq Down 0.35%

    More On BLRX

    BioLineRx, Ltd. (BLRX)

    -NasdaqCM
    1.69 Up 0.11(6.96%) Sep 3, 4:00PM EDT
    Add to Portfolio
    Prev Close:1.58
    Open:1.61
    Bid:1.01 x 100
    Ask:1.79 x 100
    1y Target Est:4.83
    Beta:1.10994
    Next Earnings Date:N/A
    Day's Range:1.57 - 1.73
    52wk Range:1.03 - 3.28
    Volume:429,880
    Avg Vol (3m):790,080
    Market Cap:92.20M
    P/E (ttm):N/A
    EPS (ttm):-0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BLRX

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.28
    Quarterly EPS Est (Jun-15) :-0.08
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioLineRx Ltd., a clinical stage biopharmaceutical development company, engages in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback